0.12Open0.12Pre Close0 Volume10 Open Interest6.00Strike Price0.00Turnover360.56%IV87.73%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier7DDays to Expiry0.12Extrinsic Value100Contract SizeAmericanOptions Type0.1692Delta0.1537Gamma27.17Leverage Ratio-0.0286Theta0.0001Rho4.60Eff Leverage0.0011Vega
CureVac Stock Discussion
Benzinga· 1 min ago
New trial date for U.S. patent litigation set for March 3, 2025, following settlement with Acuitas Therapeutics.
First instance decision on validity of EP 3 708 668 B1 (split poly-A tail technology) scheduled for March 25, 2025, by European Patent Office in the context of the German patent liti...
loading...
No comment yet